Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.

Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.

Habert MO, Horn JF, Sarazin M, Lotterie JA, Puel M, Onen F, Zanca M, Portet F, Touchon J, Verny M, Mahieux F, Giron A, Fertil B, Dubois B.

Neurobiol Aging. 2011 Jan;32(1):15-23. doi: 10.1016/j.neurobiolaging.2009.01.013. Epub 2009 Feb 27.

PMID:
19250707
2.

A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.

Alegret M, Cuberas-Borrós G, Vinyes-Junqué G, Espinosa A, Valero S, Hernández I, Roca I, Ruíz A, Rosende-Roca M, Mauleón A, Becker JT, Castell-Conesa J, Tárraga L, Boada M.

J Alzheimers Dis. 2012;30(1):109-20. doi: 10.3233/JAD-2012-111850.

3.

Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.

Encinas M, De Juan R, Marcos A, Gil P, Barabash A, Fernández C, De Ugarte C, Cabranes JA.

Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1473-80. Epub 2003 Aug 15.

PMID:
14579086
4.

Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.

Nobili F, Brugnolo A, Calvini P, Copello F, De Leo C, Girtler N, Morbelli S, Piccardo A, Vitali P, Rodriguez G.

Clin Neurophysiol. 2005 Feb;116(2):364-75.

PMID:
15661114
5.

Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.

Ito K, Shimano Y, Imabayashi E, Nakata Y, Omachi Y, Sato N, Arima K, Matsuda H.

Int J Geriatr Psychiatry. 2014 Oct;29(10):1079-86. doi: 10.1002/gps.4102. Epub 2014 Mar 29.

PMID:
24687634
6.

(99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.

Devanand DP, Van Heertum RL, Kegeles LS, Liu X, Jin ZH, Pradhaban G, Rusinek H, Pratap M, Pelton GH, Prohovnik I, Stern Y, Mann JJ, Parsey R.

Am J Geriatr Psychiatry. 2010 Nov;18(11):959-72. doi: 10.1097/JGP.0b013e3181ec8696.

7.

Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.

Borroni B, Anchisi D, Paghera B, Vicini B, Kerrouche N, Garibotto V, Terzi A, Vignolo LA, Di Luca M, Giubbini R, Padovani A, Perani D.

Neurobiol Aging. 2006 Jan;27(1):24-31. Epub 2005 Mar 24.

PMID:
16298237
8.

Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease.

Alegret M, Vinyes-Junqué G, Boada M, Martínez-Lage P, Cuberas G, Espinosa A, Roca I, Hernández I, Valero S, Rosende-Roca M, Mauleón A, Becker And JT, Tárraga L.

J Alzheimers Dis. 2010;21(2):557-67. doi: 10.3233/JAD-2010-091069.

9.

Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.

Alegret M, Cuberas-Borrós G, Espinosa A, Valero S, Hernández I, Ruíz A, Becker JT, Rosende-Roca M, Mauleón A, Sotolongo O, Castell-Conesa J, Roca I, Tárraga L, Boada M.

J Alzheimers Dis. 2014;41(3):739-48. doi: 10.3233/JAD-132516.

10.

Relevance of functional neuroimaging in the progression of mild cognitive impairment.

Cabranes JA, De Juan R, Encinas M, Marcos A, Gil P, Fernández C, De Ugarte C, Barabash A.

Neurol Res. 2004 Jul;26(5):496-501.

PMID:
15265266
11.

Trail making test B and brain perfusion imaging in mild cognitive impairment and mild Alzheimer's disease.

Terada S, Sato S, Nagao S, Ikeda C, Shindo A, Hayashi S, Oshima E, Yokota O, Uchitomi Y.

Psychiatry Res. 2013 Sep 30;213(3):249-55. doi: 10.1016/j.pscychresns.2013.03.006. Epub 2013 Jul 5.

PMID:
23830931
12.

Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.

Nobili F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, Touchon J, Calvini P, Morbelli S, De Carli F, Guerra UP, Van de Pol LA, Visser PJ.

J Neurol. 2008 Sep;255(9):1344-53. doi: 10.1007/s00415-008-0897-4. Epub 2008 Aug 1.

PMID:
18958573
13.

[Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].

Banzo I, Quirce R, Martínez-Rodríguez I, Jiménez-Bonilla J, Portilla-Quattrociocchi H, Medina-Quiroz P, Ortega F, Rodríguez E, Mateo I, Vázquez-Higuera JL, de Arcocha M, Carril JM.

Rev Esp Med Nucl. 2011 Sep-Oct;30(5):301-6. doi: 10.1016/j.remn.2011.03.010. Epub 2011 Jun 2. Spanish.

14.
15.

[Prediction of progression in patients with mild cognitive impairment using IMP-SPECT].

Okamura N, Shinkawa M, Arai H, Matsui T, Nakajo K, Maruyama M, Hu XS, Sasaki H.

Nihon Ronen Igakkai Zasshi. 2000 Dec;37(12):974-8. Japanese.

16.

SPECT predictors of cognitive decline and Alzheimer's disease in mild cognitive impairment.

Nobili F, De Carli F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, Touchon J, Morbelli S, Guerra UP, Dessi B, Brugnolo A, Visser PJ.

J Alzheimers Dis. 2009;17(4):761-72. doi: 10.3233/JAD-2009-1091.

PMID:
19542623
17.
18.

Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.

Park KW, Yoon HJ, Kang DY, Kim BC, Kim S, Kim JW.

Psychiatry Res. 2012 Aug-Sep;203(2-3):201-6. doi: 10.1016/j.pscychresns.2011.12.007. Epub 2012 Sep 12.

PMID:
22980226
19.

Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: a qualitative and quantitative SPECT study.

Ishiwata A, Sakayori O, Minoshima S, Mizumura S, Kitamura S, Katayama Y.

Acta Neurol Scand. 2006 Aug;114(2):91-6.

PMID:
16867030
20.

99mTc-HMPAO and 99mTc-ECD brain uptake correlates of verbal memory in Alzheimer's disease.

Nobili F, Koulibaly PM, Rodriguez G, Benoit M, Girtler N, Robert PH, Brugnolo A, Darcourt J.

Q J Nucl Med Mol Imaging. 2007 Dec;51(4):357-63.

Supplemental Content

Support Center